1. Summary of characteristics of studies.
Study ID | Total number of participants | Intervention (n) | Comparison (N) | Country | *Primary outcomes reported | **Secondary outcomes reported | |||||||
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |||||
Eryilmaz 2005 | 45 | Needle aspiration without ultrasound (n = 22) | I&D (n = 23) | Turkey | Y | N | Y | N | N | Y | N | Y | N |
Saleem 2008 | 60 | Percutaneous ultrasound‐guided drainage (n = 30) | I&D (n = 30) | Pakistan | Y | Y | N | Y | N | Y | Y | Y | N |
Singla 2002 | 150 | All women underwent (I&D) Antibiotics (Group 1 n = 50; Group 2 n = 50) | Control (n = 50) | India | Y | N | Y | N | N | N | Y | N | N |
Suthar 2012 | 70 | Percutaneous ultrasound‐guided needle aspiration (n = 35) | Open surgical drainage (n = 35) | India | Y | Y | Y | N | N | N | Y | N | Y |
*Primary and **Secondary outcomes
- Time to complete resolution.
- Any continuation of breastfeeding after treatment.
- Treatment failure .
- Number of follow‐up visits.
- Duration of continuation of breastfeeding after treatment.
- Maternal satisfaction with treatment.
- Post‐operative complications/morbidity.
- Duration of hospital stay.
- Adverse events.
I&D: incision and drainage